Sign up
Log in
Keysight Technologies (NYSE:KEYS) Powers AMD's Next-Gen CPU Testing With PCIe 6.0 Integration
Share
Listen to the news

Keysight Technologies (NYSE:KEYS) recently collaborated with AMD to advance PCI Express 6.0 technology, marking a significant step in high-speed data transfer and AI application development. Over the past quarter, the company experienced a 3% stock price increase, aligning closely with the market's modest gains. While the market has shown a 10% rise this year and anticipates 15% annual earnings growth, Keysight's performance was supported by its strong Q2 earnings and share buyback activities. These elements collectively reinforced the company's positive trajectory amid the broader market context, with no standout divergences from overall trends.

Buy, Hold or Sell Keysight Technologies? View our complete analysis and fair value estimate and you decide.

NYSE:KEYS Revenue & Expenses Breakdown as at Jun 2025
NYSE:KEYS Revenue & Expenses Breakdown as at Jun 2025

Rare earth metals are the new gold rush. Find out which 24 stocks are leading the charge.

The collaboration between Keysight Technologies and AMD on PCI Express 6.0 technology could bolster revenue and earnings forecasts by enhancing the company's product offerings in high-speed data transfer and AI applications. This alignment with industry advancements is expected to strengthen Keysight's market position, potentially driving further growth in their software-centric and recurring revenue streams. As a result, this partnership may enhance the company's attractiveness to investors and improve its competitive edge in the evolving tech landscape.

Over the past five years, Keysight Technologies achieved a total return of 58.19%, reflecting consistent performance and resilience in a competitive market. This long-term gain provides context for the company's overall stock trajectory, supported by its strategic initiatives and diverse product portfolio. In contrast, during the past year, Keysight's return has outpaced the US Market, which generated a 9.8% rise, underscoring its robust positioning relative to industry peers.

The recent news could position Keysight to capitalize on growing demand in AI and data centers, potentially enhancing its revenue growth from the current 6% annual forecast. Moreover, aided by strategic acquisitions and collaboration, Keysight may experience improved margins and earnings stability. While its current share price of US$163.61 remains roughly 10.8% below the analyst consensus target of US$183.44, the emerging technology synergies may contribute positively towards closing this valuation gap. These developments could affirm analyst expectations if Keysight continues leveraging high-growth areas and optimizing its product mix.

Our comprehensive valuation report raises the possibility that Keysight Technologies is priced higher than what may be justified by its financials.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.